Latest News and Press Releases

Market growth is fueled by rising R&D investments, increasing trial complexity, and demand for faster, more cost-effective drug development.

Delray Beach, FL, Jan. 20, 2026 (GLOBE NEWSWIRE) -- The Methyl Cellulose Market size is valued at USD 3.64 billion in 2025 and is expected to reach USD 5.88 billion by 2030, at a CAGR of 10.0%...

Quoin Pharmaceuticals Files Breakthrough Medicine Designation Application in Saudi Arabia for QRX003 in Netherton Syndrome

CHASKA, Minn., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and manufacturing organization (“CDMO”), today...

Anresco NJ Labs has expanded its laboratory network with aligned facilities on both the East and West Coasts.

First patient dosed and study open in leading oncology centers in US and AustraliaPhase I/IIA adaptive study aims to assess and optimize the dose of OTP-01 and provide safety, tolerability, and early...

BRISBANE, Australia and CAMBRIDGE, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Vaxxas Pty Ltd today announced the appointment of global biopharmaceutical executive Mr David Peacock as Chief Executive...

BGB Group strengthens pharma commercialization capabilities by integrating Hayden's payer and reimbursement expertise into its advisory practice.

CHASKA, Minn., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...

U.S. JPML has created a new multidistrict litigation for lawsuits alleging that GLP-1 receptor agonist drugs cause NAION, a serious vision injury.